Supplemental material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma
Beatriz Asenjo García
Félix Navarro Guirado
Fátima Nagib Raya
María Vidal Denis
Francisco Bravo Rodríguez
Pedro Galán Montenegro
10.25384/SAGE.9167210.v1
https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_ADC_quantification_to_classify_patients_candidate_to_receive_bevacizumab_treatment_for_recurrent_glioblastoma/9167210
<p>Supplemental Material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma by Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez and Pedro Galán Montenegro in Acta Radiologica</p>
2019-07-30 12:18:32
Antiangiogenic drug
bevacizumab
glioma
imaging biomarker
magnetic resonance
diffusion-weighted imaging